Q2 2025 · 13F-HR
72 Investment Holdings, LLCholdings as filed
Filed 2025-08-14 · accession 0000902664-25-003658
$38.3M
Reported value
6
Positions
2025-06-30
Period end
The Brief · 72 Investment Holdings, LLC · Q2 2025
AI · grounded in 13F
72 Investment Holdings, LLC established a new position in LENZ valued at $29.8M. The fund also initiated stakes in KRRO for $3.5M and PRAX for $2.8M. Other new additions include ANRO, CRBU, and Turnstone Biologics Corp.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 52635N103 | LENZ | LENZ THERAPEUTICS INC | $29.8M | 77.8% | 1,017,751 | Common | SHARED |
| 500946108 | KRRO | KORRO BIO INC | $3.5M | 9.02% | 276,831 | Common | SHARED |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES I | $2.8M | 7.23% | 65,933 | Common | SHARED |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1.5M | 3.83% | 667,778 | Common | SHARED |
| 142038108 | CRBU | CARIBOU BIOSCIENCES INC | $597,324 | 1.56% | 474,067 | Common | SHARED |
| 90042W100 | — | TURNSTONE BIOLOGICS CORP | $197,443 | 0.52% | 549,980 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.